| Literature DB >> 19396021 |
Jovanka Kolarovic1, Mira Popovic, Momir Mikov, Radoslav Mitic, Ljiljana Gvozdenovic.
Abstract
The aim of this work was to investigate possible protective effect of celery juice in doxorubicin treatment. The following biochemical parameters were determined: content of reduced glutathione, activities of catalase, xanthine oxidase, glutathione peroxidase, peroxidase, and lipid peroxidation intensity in liver homogenate and blood hemolysate. We examined influence of diluted pure celery leaves and roots juices and their combinations with doxorubicine on analyzed biochemical parameters. Celery roots and leaves juices influenced the examined biochemical parameters and showed protective effects when applied with doxorubicine.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19396021 PMCID: PMC6254272 DOI: 10.3390/molecules14041627
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Investigated Biochemical Parameters in Liver Homogenate (mean±SD).
| CON | CR | CL | D | CRD | CLD | |
|---|---|---|---|---|---|---|
|
| 0.45±0.06 | 0.40±0,11 | 0.22±0.09a | 0,35±0,06 | 0.37±0.08 | 0.34±0,06 |
|
| 2,24±0.19 | 4.69±1.31b | 3.35±0.70a | 2.16±0.14 | 4.19±0.80b | 3.34±0.36a |
|
| 0.71±0.13 | 1.13±0.17a | 0.95±0.08a | 0.74±0.24 | 0.81±0.04 | 0.96±0.09 |
|
| 2.15±0.65 | 4.54±0.61c | 3.34±0.13a | 3.95±0.64a | 2.98±0.38 | 2.87±0.80 |
|
| 4.52±0.99 | 6.86±1.13b | 5.94±0.99a | 3.97±0.57 | 5.72±0.40a | 4.51±0.76 |
|
| 12.20±1.63 | 19.29±1.02c | 16.42±3.05a | 10.72±1.79 | 9.31±0.86b | 7.92±1.78b |
a p<0.05, b p<0.01, c p<0.001, t-test, n = 6; x ± SD. Content of GSH is expressed in nmol GSH/mg of protein. Activities of XOD, GSH-Px, GSHR, Px, CAT are expressed in nmol/mg of protein min-1. Content of LPx is expressed in nmol malondialdehyde/mg of protein.
ANOVA Test for Biochemical Parameters Analyzed in Liver Homogenate.
| LPx | CON | CR | CL | CRD | CLD | XOD | CON | CR | CL | CRD | CLD |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.05 | 2.44 | ||||||||||
| 0.23 | 0.18 | 1.20 | 1.24 | ||||||||
| 0.08 | 0.04 | 0.15 | 1.94 | 0.50 | 0.74 | ||||||
| 0.11 | 0.06 | 0.12 | 0.03 | 1.09 | 1.35 | 0.11 | 0.85 | ||||
| 0.10 | 0.05 | 0.14 | 0.01 | 0.02 | 0.09 | 2.53 | 1.29 | 2.03 | 1.19 | ||
| 0.42 | 2.35 | ||||||||||
| 0.11 | 0.31 | 1.42 | 0.93 | ||||||||
| 0.24 | 0.18 | 0.14 | 1.20 | 1.15 | 0.22 | ||||||
| 0.25 | 0.17 | 0.14 | 0.01 | 0.01 | 2.36 | 1.43 | 1.21 | ||||
| 0.04 | 0.38 | 0.14 | 0.21 | 0.22 | 0.54 | 2.89 | 1.96 | 1.75 | 0.53 | ||
| 2.39 | 7.09 | ||||||||||
| 1.23 | 1.16 | 4.22 | 2.88 | ||||||||
| 0.83 | 1.56 | 0.40 | 2.88 | 9.98 | 7.10 | ||||||
| 0.72 | 1.67 | 0.51 | 0.11 | 4.28 | 11.37 | 8.50 | 1.39 | ||||
| 1.80 | 0.58 | 0.58 | 0.97 | 1.09 | 1.48 | 8.58 | 5.70 | 1.40 | 2.80 |
Investigated Biochemical Parameters in Blood Hemolysate (mean±SD).
| CON | CR | CL | D | CRD | CLD | |
|---|---|---|---|---|---|---|
| 0.27± 0.04 | 0.22 ± 0.01a | 0.18 ± 0.03b | 0.20 ± 0.02 b | 0.21± 0.02a | 0.21± 0.02a | |
| 2.66 ± 0.19 | 2.40 ± 0.36 | 2.34 ± 0.25a | 2.27 ± 0.21a | 2.98 ± 0.43 | 2.53 ± 0.37 | |
| 2.12 ± 0.22 | 1.73 ± 0.11b | 1.83 ± 0.11b | 1.84 ± 0.12a | 1.79 ± 0.18a | 1.76 ± 0.14 b | |
| 1.86 ± 0.06 | 1.63 ± 0.16 a | 1.40 ± 0.06c | 1.36 ± 0.13c | 1.59 ± 0.13 b | 1.50 ± 0.24a | |
| 6.63 ± 0.34 | 6.23 ± 0.44 | 5.51 ± 0.39c | 5.12 ± 0.19c | 5.72 ± 0.72a | 5.82 ± 0.33b | |
| 1.47 ± 0.18 | 1.32 ± 0.11 | 1.20 ± 0.15a | 0.87 ± 0.11c | 1.18 ± 0.11a | 1.13 ± 0.16b |
a p<0.05, b p<0.01, c p<0.001, t-test, n = 6; x ± SD. Content of GSH is expressed in nmol GSH/mL erythtrocytes. Activities of XOD, GSH-Px, GSHR, Px, CAT are expressed in nmol/mL erythtrocytes min-1. Content of LPx is expressed in nmol malondialdehyde/mL erythtrocytes.
ANOVA Test for Biochemical Parameters Measured in Blood Hemolysate.
| LPx | CON | CR | CL | CRD | CLD | XOD | CON | CR | CL | CRD | CLD |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.04 | 0.26 | ||||||||||
| 0.08 | 0.04 | 0.33 | 0.06 | ||||||||
| 0.06 | 0.02 | 0.02 | 0.32 | 0.58 | 0.65 | ||||||
| 0.05 | 0.01 | 0.03 | 0.01 | 0.13 | 0.13 | 0.19 | 0.45 | ||||
| 0.06 | 0.02 | 0.02 | 0.00 | 0.01 | 0.39 | 0.13 | 0.06 | 0.71 | 0.26 | ||
| 0.39 | 0.40 | ||||||||||
| 0.29+ | 0.10 | 1.12 | 0.72 | ||||||||
| 0.33 | 0.06 | 0.04 | 0.91 | 0.51 | 0.21 | ||||||
| 0.36 | 0.03 | 0.07 | 0.03 | 0.81 | 0.41 | 0.31 | 0.10 | ||||
| 0.28 | 0.11 | 0.02 | 0.05 | 0.08 | 1.50 | 1.11 | 0.39 | 0.59 | 0.69 | ||
| 0.23 | 0.14 | ||||||||||
| 0.46 | 0.23 | 0.26 | 0.12 | ||||||||
| 0.27 | 0.04 | 0.19 | 0.28 | 0.14 | 0.02 | ||||||
| 0.35 | 0.13 | 0.10 | 0.08 | 0.34 | 0.19 | 0.07 | 0.05 | ||||
| 0.50 | 0.27 | 0.04 | 0.22 | 0.14 | 0.59 | 0.45 | 0.33 | 0.31 | 0.26 |
Results of the ANOVA test are represented for the differences between groups for the confidence level p<0.05; + statistically significant p < 0.05; - statistically nonsignificant p > 0.05; LPx: F = 2.95; p<0.05; D=0.02; XOD: F = 3.63; p<0.01; D = 0.20; CAT: F = 1.63; p>0.05; D = 0.16; Px: F= 9.95; p<0.001; D=0.09; GSHPx: F= 9.78, p<0.001; D = 0.29; GSH: F= 18.51, p<0.001; D = 0.09.